Feng Yu

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

Human cell

Tumori

Biotechnology letters

This page only lists publications with an associated author ORCID identifier.

Publications

Anran Dai, Xiangzhi Zhang, Xiaoyan Wang, Guodong Liu, Qiang Wang, Feng Yu
Transcription factors in chimeric antigen receptor T-cell development. Human cell 37 (3) (2024)
Xiaoyan Wang, Guodong Liu, Tian Huan, Yuxing Wang, Bo Jiang, Wei Liu, Anran Dai, Xiangzhi Zhang, Feng Yu
Synergistic effect of chimeric antigen receptor modified with Bcl-2 on enhanced solid tumour targeting. Human cell (2024)
Xiaoyan Wang, Guodong Liu, Xianggang Shi, Yuxing Wang, Bo Jiang, Wei Liu, Anran Dai, Xiangzhi Zhang, Feng Yu
Overexpressing Bcl-2 enhances murine chimeric antigen receptor T cell therapy against solid tumor. Human cell 37 (4) (2024)
Anran Dai, Xiangzhi Zhang, Xiaoyan Wang, Guodong Liu, Qiang Wang, Feng Yu
Transcription factors in chimeric antigen receptor T-cell development. Human cell (2024)
Xiaoyan Wang, Guodong Liu, Tian Huan, Yuxing Wang, Bo Jiang, Wei Liu, Anran Dai, Xiangzhi Zhang, Feng Yu
Synergistic effect of chimeric antigen receptor modified with Bcl-2 on enhanced solid tumour targeting. Human cell 37 (5) (2024)
Xiaoyan Wang, Guodong Liu, Xianggang Shi, Yuxing Wang, Bo Jiang, Wei Liu, Anran Dai, Xiangzhi Zhang, Feng Yu
Overexpressing Bcl-2 enhances murine chimeric antigen receptor T cell therapy against solid tumor. Human cell (2024)
Anran Dai, Xiangzhi Zhang, Xiaoyan Wang, Guodong Liu, Qiang Wang, Feng Yu
Transcription factors in chimeric antigen receptor T-cell development. Human cell 37 (3) (2024)
Xiaoyan Wang, Guodong Liu, Tian Huan, Yuxing Wang, Bo Jiang, Wei Liu, Anran Dai, Xiangzhi Zhang, Feng Yu
Synergistic effect of chimeric antigen receptor modified with Bcl-2 on enhanced solid tumour targeting. Human cell 37 (5) (2024)
Anran Dai, Xiangzhi Zhang, Xiaoyan Wang, Guodong Liu, Qiang Wang, Feng Yu
Transcription factors in chimeric antigen receptor T-cell development. Human cell 37 (3) (2024)
Xiaoyan Wang, Guodong Liu, Xianggang Shi, Yuxing Wang, Bo Jiang, Wei Liu, Anran Dai, Xiangzhi Zhang, Feng Yu
Overexpressing Bcl-2 enhances murine chimeric antigen receptor T cell therapy against solid tumor. Human cell 37 (4) (2024)
Tian Huan, Dongfeng Chen, Guodong Liu, Hailing Zhang, Xiaoyan Wang, Zhi Wu, Yan Wu, Qinggang Xu, Feng Yu
Activation-induced cell death in CAR-T cell therapy. Human cell 35 (2) (2022)
Yang Gao, Yan Wu, Tian Huan, Xiaoyan Wang, Jun Xu, Qinggang Xu, Feng Yu, Haifeng Shi
The application of oncolytic viruses in cancer therapy. Biotechnology letters 43 (10) (2021)
Feng Yu, Xiaoyan Wang, Hui Shi, Maorong Jiang, Jun Xu, Min Sun, Qinggang Xu, Frank Peprah Addai, Haifeng Shi, Jie Gu, Yang Zhou, Liqiong Liu
Development of chimeric antigen receptor-modified T cells for the treatment of esophageal cancer. Tumori 107 (4) (2020)

Feng Yu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Feng Yu